For all three heterologous A(H3N2) viruses, the qHA-NA and qNA groups exhibited higher cross-neutralizing titers than the qHA group (Fig. 5a), supporting the value of including NA in future quadrivalent influenza vaccines. The gene discussed is XK; the disease is influenza.